🟢 GT Biopharma is trading 8.24% up today amid broad risk-on market gains

GT Biopharma is trading at $7.75, up 8.24%, as U.S. markets opened higher on September 21, 2026, supporting broader risk appetite.

• The S&P 500, Nasdaq Composite, and Dow Jones are gaining 1.01%, 1.61%, and 0.47%, respectively.
• No new company-specific announcement was identified for September 21.
• Recent FDA clearance for GTB-5550 and financing news remain relevant background, but available evidence points mainly to broad market strength rather than a fresh company catalyst.